Perceptive Advisors LLC Vyne Therapeutics Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.5 - $1.15 $1.09 Million - $2.5 Million	-2,178,022 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.91 - $1.5 $138,728 - $228,673	-152,449 Reduced 6.54%	2,178,022 $2.22 Million
Q3 2021 Nov 15, 2021	SELL	$1.39 - $3.47 $4.79 Million - $11.9 Million	-3,443,483 Reduced 59.64%	2,330,471 $3.24 Million
Q2 2021 Aug 16, 2021	SELL	$3.24 - $6.92 $3.24 Million - $6.92 Million	-1,000,000 Reduced 14.76%	5,773,954 $20.3 Million
Q1 2021 May 17, 2021	BUY	$6.34 - $12.68 $42.9 Million - $85.9 Million	6,773,954 New	6,773,954 $46.4 Million

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $157M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.